GRM5 and Huntington disease: Glutamate hyperactivity plays a prominent role in HD (Andre et al., 2010) and can activate mTORC1 via the mGluR5-PDK1-Akt-mTORC1 pathway (Abd-Elrahman and Ferguson, 2019).